Mouse models of intestinal cancer

Jackstadt, R. and Sansom, O. (2016) Mouse models of intestinal cancer. Journal of Pathology, 238(2), pp. 141-151. (doi: 10.1002/path.4645) (PMID:26414675) (PMCID:PMC4832380)

115583.pdf - Published Version
Available under License Creative Commons Attribution.



Murine models of intestinal cancer are powerful tools to recapitulate human intestinal cancer, understand its biology and test therapies. With recent developments identifying the importance of the tumour microenvironment and the potential for immunotherapy, autochthonous genetically engineered mouse models (GEMMs) will remain an important part of preclinical studies for the foreseeable future. This review will provide an overview of the current mouse models of intestinal cancer, from the ApcMin/+ mouse, which has been used for over 25 years, to the latest ‘state-of-the-art’ organoid models. We discuss here how these models have been used to define fundamental processes involved in tumour initiation and the attempts to generate metastatic models, which is the ultimate cause of cancer mortality. Together these models will provide key insights to understand this complex disease and hopefully will lead to the discovery of new therapeutic strategies.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Sansom, Professor Owen
Authors: Jackstadt, R., and Sansom, O.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Journal of Pathology
ISSN (Online):1096-9896
Copyright Holders:Copyright © 2015 The Authors
First Published:First published in Journal of Pathology 238(2):141-151
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
647981CR-UK Centre renewalKaren VousdenCancer Research UK (CAN-RES-UK)18076RI CANCER SCIENCES